DOSIsoft has announced the release of PLANET Onco Dose version 3.2, a multi-radionuclide dosimetry platform that has received FDA 510(k) clearance in the U.S. and CE Mark approval in the EU. This advanced software supports personalized voxel-based dosimetry for various isotopes used in radionuclide therapies, enhancing clinical workflows and patient comfort. The platform integrates multiple radionuclides and therapy applications, including treatments like 177Lu-PSMA and 90Y radioembolization. The CEO of DOSIsoft noted the achievement reflects their commitment to quality and safety, aiming to benefit patients worldwide.
Tue, 08 Apr 2025 21:49:15 GMT | Imaging Technology News